Menopause is an aging process and an important time equivalent to one-third of a woman's lifetime. Menopause significantly increases the risk of cardiometabolic diseases, such as obesity, type 2 diabetes, cardiovascular diseases, non-alcoholic liver disease (NAFLD)/metabolic associated fatty liver disease (MFFLD), and metabolic syndrome (MetS). Women experience a variety of symptoms in the perimenopausal period, and these symptoms are distressing for most women. Many factors worsen a woman's menopausal experience, and controlling these factors may be a strategy to improve postmenopausal women's health. This review aimed to confirm the association between menopause and metabolic diseases (especially MetS), including pathophysiology, definition, prevalence, diagnosis, management, and prevention.
Keyphrases
- postmenopausal women
- bone mineral density
- metabolic syndrome
- type diabetes
- insulin resistance
- polycystic ovary syndrome
- cardiovascular disease
- healthcare
- public health
- pregnancy outcomes
- risk factors
- weight loss
- cervical cancer screening
- mental health
- sleep quality
- cardiovascular risk factors
- body mass index
- breast cancer risk
- risk assessment
- liver injury
- pregnant women
- uric acid
- high fat diet induced
- cardiovascular events
- drug induced
- human health
- physical activity